Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release
In nanoplatform-based tumor treatment, combining chemotherapy with hyperthermia therapy is an interesting strategy to achieve enhanced therapeutic efficacy with low dose of delivery drugs. Compared to photothermal therapy, magnetic hyperthermia has few restrictions on penetrating tissue by an altern...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-12-01
|
Series: | Science and Technology of Advanced Materials |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14686996.2019.1682467 |
id |
doaj-b8930e7208b147d38ff667752fd010a7 |
---|---|
record_format |
Article |
spelling |
doaj-b8930e7208b147d38ff667752fd010a72020-11-25T03:45:56ZengTaylor & Francis GroupScience and Technology of Advanced Materials1468-69961878-55142019-12-012011043105410.1080/14686996.2019.16824671682467Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug releaseJiajie Chen0Jiaxing Liu1Yaping Hu2Zhengfang Tian3Yufang Zhu4University of Shanghai for Science and TechnologyUniversity of Shanghai for Science and TechnologyUniversity of Shanghai for Science and TechnologyHuanggang Normal UniversityUniversity of Shanghai for Science and TechnologyIn nanoplatform-based tumor treatment, combining chemotherapy with hyperthermia therapy is an interesting strategy to achieve enhanced therapeutic efficacy with low dose of delivery drugs. Compared to photothermal therapy, magnetic hyperthermia has few restrictions on penetrating tissue by an alternating magnetic field, and thereby could cure various solid tumors, even deep-tissue ones. In this work, we proposed to construct magnetic nanocomposites (Fe3O4@PDA@ZIF-90) by the external growth of metal-organic framework ZIF-90 on polydopamine (PDA)-coated Fe3O4 nanoparticles for synergistic magnetic hyperthermia and chemotherapy. In such multifunctional platform, Fe3O4 nanoparticle was utilized as a magnetic heating seed, PDA layer acted as an inducer for the growth of ZIF-90 shell and porous ZIF-90 shell served as drug nanocarrier to load doxorubicin (DOX). The well-defined Fe3O4@PDA@ZIF-90 core-shell nanoparticles were displayed with an average size of ca. 200 nm and possessed the abilities to load high capacity of DOX as well as trigger drug release in a pH-responsive way. Furthermore, the Fe3O4@PDA@ZIF-90 nanoparticles can raise the local temperature to meet hyperthermia condition under an alternating magnetic field owing to the magnetocaloric effect of Fe3O4 cores. In the in vitro experiments, the Fe3O4@PDA@ZIF-90 nanoparticles showed a negligible cytotoxicity to Hela cells. More significantly, after cellular internalization, the DOX-loaded Fe3O4@PDA@ZIF-90 nanoparticles exhibited distinctively synergistic effect to kill tumor cells with higher efficacy compared to chemotherapy or magnetic hyperthermia alone, presenting a great potential for efficient tumor therapy.http://dx.doi.org/10.1080/14686996.2019.1682467multifunctional nanoparticlesmetal-organic frameworksmagnetic hyperthermiachemotherapysynergistic effect |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jiajie Chen Jiaxing Liu Yaping Hu Zhengfang Tian Yufang Zhu |
spellingShingle |
Jiajie Chen Jiaxing Liu Yaping Hu Zhengfang Tian Yufang Zhu Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release Science and Technology of Advanced Materials multifunctional nanoparticles metal-organic frameworks magnetic hyperthermia chemotherapy synergistic effect |
author_facet |
Jiajie Chen Jiaxing Liu Yaping Hu Zhengfang Tian Yufang Zhu |
author_sort |
Jiajie Chen |
title |
Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release |
title_short |
Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release |
title_full |
Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release |
title_fullStr |
Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release |
title_full_unstemmed |
Metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with pH-triggered drug release |
title_sort |
metal-organic framework-coated magnetite nanoparticles for synergistic magnetic hyperthermia and chemotherapy with ph-triggered drug release |
publisher |
Taylor & Francis Group |
series |
Science and Technology of Advanced Materials |
issn |
1468-6996 1878-5514 |
publishDate |
2019-12-01 |
description |
In nanoplatform-based tumor treatment, combining chemotherapy with hyperthermia therapy is an interesting strategy to achieve enhanced therapeutic efficacy with low dose of delivery drugs. Compared to photothermal therapy, magnetic hyperthermia has few restrictions on penetrating tissue by an alternating magnetic field, and thereby could cure various solid tumors, even deep-tissue ones. In this work, we proposed to construct magnetic nanocomposites (Fe3O4@PDA@ZIF-90) by the external growth of metal-organic framework ZIF-90 on polydopamine (PDA)-coated Fe3O4 nanoparticles for synergistic magnetic hyperthermia and chemotherapy. In such multifunctional platform, Fe3O4 nanoparticle was utilized as a magnetic heating seed, PDA layer acted as an inducer for the growth of ZIF-90 shell and porous ZIF-90 shell served as drug nanocarrier to load doxorubicin (DOX). The well-defined Fe3O4@PDA@ZIF-90 core-shell nanoparticles were displayed with an average size of ca. 200 nm and possessed the abilities to load high capacity of DOX as well as trigger drug release in a pH-responsive way. Furthermore, the Fe3O4@PDA@ZIF-90 nanoparticles can raise the local temperature to meet hyperthermia condition under an alternating magnetic field owing to the magnetocaloric effect of Fe3O4 cores. In the in vitro experiments, the Fe3O4@PDA@ZIF-90 nanoparticles showed a negligible cytotoxicity to Hela cells. More significantly, after cellular internalization, the DOX-loaded Fe3O4@PDA@ZIF-90 nanoparticles exhibited distinctively synergistic effect to kill tumor cells with higher efficacy compared to chemotherapy or magnetic hyperthermia alone, presenting a great potential for efficient tumor therapy. |
topic |
multifunctional nanoparticles metal-organic frameworks magnetic hyperthermia chemotherapy synergistic effect |
url |
http://dx.doi.org/10.1080/14686996.2019.1682467 |
work_keys_str_mv |
AT jiajiechen metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease AT jiaxingliu metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease AT yapinghu metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease AT zhengfangtian metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease AT yufangzhu metalorganicframeworkcoatedmagnetitenanoparticlesforsynergisticmagnetichyperthermiaandchemotherapywithphtriggereddrugrelease |
_version_ |
1724508852320206848 |